141 related articles for article (PubMed ID: 26993659)
21. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.
Kesselring R; Thiel A; Pries R; Trenkle T; Wollenberg B
Br J Cancer; 2010 Oct; 103(8):1245-54. PubMed ID: 20877351
[TBL] [Abstract][Full Text] [Related]
22. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
23. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
24. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
[TBL] [Abstract][Full Text] [Related]
25. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
[TBL] [Abstract][Full Text] [Related]
26. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
Strauss L; Volland D; Kunkel M; Reichert TE
Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
[TBL] [Abstract][Full Text] [Related]
27. Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C.
Kim HY; Rha KS; Shim GA; Kim JH; Kim JM; Huang SM; Koo BS
Oncol Rep; 2015 Aug; 34(2):833-42. PubMed ID: 26081937
[TBL] [Abstract][Full Text] [Related]
28. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
[TBL] [Abstract][Full Text] [Related]
29. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
30. Erratum to: Significance of endothelial progenitor cells (EPC) for tumorigenesis of head and neck squamous cell carcinoma (HNSCC): possible marker of tumor progression and neovascularization?
Ziebart T; Blatt S; Günther C; Voelxen N; Pabst A; Sagheb K; Kühl S; Lambrecht T
Clin Oral Investig; 2016 Nov; 20(8):2301. PubMed ID: 27108343
[No Abstract] [Full Text] [Related]
31. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
[TBL] [Abstract][Full Text] [Related]
32. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
33. Endothelial progenitor cells are mobilized after major laparotomic surgery in patients with cancer.
Schillaci G; Rondelli F; Pirro M; Bagaglia F; Pucci G; Noya G; Mannarino E
Int J Immunopathol Pharmacol; 2009; 22(4):1035-41. PubMed ID: 20074467
[TBL] [Abstract][Full Text] [Related]
34. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
[TBL] [Abstract][Full Text] [Related]
35. Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
Su YY; Chien CY; Luo SD; Huang TL; Lin WC; Fang FM; Chiu TJ; Chen YH; Lai CC; Hsu CM; Li SH
World J Surg Oncol; 2016 Mar; 14():86. PubMed ID: 27001663
[TBL] [Abstract][Full Text] [Related]
36. Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma.
De Boeck A; Narine K; De Neve W; Mareel M; Bracke M; De Wever O
Oral Oncol; 2010 May; 46(5):336-42. PubMed ID: 20219413
[TBL] [Abstract][Full Text] [Related]
37. Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression.
Li YJ; Lai WT; Chang CC; Kuo MY; Deng YT; Yang CN; Cheng SJ; Wu TS; Chen ST; Lin BR
Oral Oncol; 2017 Mar; 66():100-107. PubMed ID: 28012797
[TBL] [Abstract][Full Text] [Related]
38. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
40. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
